Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients (CROSBI ID 645988)
Prilog sa skupa u časopisu | prošireni sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Batinić, Josip ; Perić, Zinaida ; Šegulja, Dragana ; Last, James ; Perković, Sanja ; Dubravčić, Klara ; Volarić, Lidija ; Sertić, Dubravka ; Radman, Ivo ; Bašić-Kinda Sandra ; Matišić, Danica ; Batinić, Drago ; Labar, Boris ; Nemet, Damir
engleski
Clinical utility of heavy/light chain assay for evaluation and prognostication in multiple myeloma patients
Evaluation of the clinical utility of the novel heavy/light chain immunoassay for the assessment of multiple myeloma patients.The novel heavy/light chain allows accurate measurement of monoclonal immunoglobulins and can be more sensitive than standard techniques at detecting residual disease. Abnormal heavy/light chain ratios and immunoglobulin isotype pair suppression may have prognostic significance for multiple myeloma patients.
multiple myeloma ; immunoglobulin, heavy/light chains, immunoassay
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2050
2014.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Blood
Washington (MD): American Society of Hematology (ASH)
1528-0020
Podaci o skupu
56th ASH Annual Meeting Abstracts
poster
06.12.2014-10.12.2014
San Francisco (CA), Sjedinjene Američke Države
